VTRS
Viatris Inc
Pharmaceutical Preparations- 売上
- $14.3bn
- 時価総額
- $21.1bn
株価 $17.76 · 100株 1,776円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $15.4bn | $14.7bn | $14.3bn |
| 成長率 | — | ▲4.5% | ▲3.0% |
| 総利益 | $6.4bn | $5.6bn | $5.0bn |
| 総利益率 | 41.8% | 38.3% | 35.2% |
| 販管費 | $4.1bn | $4.1bn | $3.8bn |
| 販管費率 | 26.4% | 27.9% | 26.6% |
| 営利 | $766m | $10m | ▲$2.7bn |
| 営利率 | 5.0% | 0.1% | ▲18.7% |
| 純利益 | $55m | ▲$634m | ▲$3.5bn |
| PBR | 1.0 | 1.1 | 1.4 |
| PSR | 1.4 | 1.4 | 1.5 |
| PGPR | 3.3 | 3.7 | 4.2 |
| PER | 385 | — | — |
| ﾈｯﾄｷｬｯｼｭ | ▲$17.1bn | ▲$13.3bn | ▲$13.1bn |
| EV/EBITDA | 10.9 | 11.8 | 252.6 |
| Rule of 40 | — | ▲4% | ▲22% |
| セールス効率 | — | ▲2,356% | — |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）